JUL 14, 2018 6:39 PM PDT

Little-known STI may Become a Superbug

WRITTEN BY: Carmen Leitch

Scientists at the British Association of Sexual Health and HIV (BASHH) are growing concerned about a common sexually transmitted infection (STI) that has the potential to become a superbug within a decade. Not many people know about mycoplasma genitalium (MG), but data collected from the US, Australia, Scandinavia and the UK determined that it infects around one percent of men and three percent of women. This research suggests that by the time people know to be wary of it, it will be resistant to drug treatment, like some other sexually transmitted diseases. 

Earlier this year, the UK reported its first case of so-called super-Gonorrhea. It’s known that pathogenic bacteria, in general, are becoming more resistant to therapeutics that used to effectively treat infections. One reason why experts are concerned about drug resistance in MG is that it is not always properly diagnosed. That can lead doctors to use the wrong drugs, which can help develop resistant strains of MG.

“MG is treated with antibiotics, but as until recently there has been no commercially available test, it has often been misdiagnosed as Chlamydia and treated as such. This is not curing the infection and is causing antimicrobial resistance in MG patients,” explained BASHH spokesperson Paddy Horner, who developed new treatment guidelines. “If practices do not change and the tests are not used, MG has the potential to become a superbug within a decade, resistant to standard antibiotics. The greatest consequence of this is for the women who present with PID [pelvic inflammatory disease] caused by MG, which would be very hard to treat, putting them at increased risk of infertility.”

MG is mistaken for Chlamydia because the symptoms, like pelvic pain or burning during urination, are similar (both can also present without symptoms). When left untreated, it can cause PID, in which infection spreads to the reproductive organs and lead to infertility.

“These new guidelines have been developed because we can’t afford to continue with the approach we have followed for the past fifteen years as this will undoubtedly lead to a public health emergency with the emergence of MG as a superbug," he added. "Our guidelines recommend that patients with symptoms are correctly diagnosed using an accurate MG test, treated correctly then followed up to make sure they are cured. Resources are urgently needed to ensure that diagnostic and antimicrobial resistance (AMR) testing is available for women with the condition who are at high risk of infertility. We are asking the [UK] government directly to make this funding available to prevent a public health emergency waiting to happen and which is already spiraling out of control”.

“MG is rapidly becoming the new ‘superbug’: it’s already increasingly resistant to most of the antibiotics we use to treat Chlamydia and changes its pattern of resistance during treatment so it’s like trying to hit a moving target. The new guidelines will be helpful, but unless and until we get funds, so we can regularly test for it, we’ll be in the dark about which women with pelvic inflammatory disease have got it, and about what their true risk of long-term complications are,” said Dr. Peter Greenhouse, sexual health consultant from Bristol.

In the United States, researchers are still trying to develop a reliable diagnostic test for MG. While one exists, it has not yet been approved by the FDA. 

 

Sources: CDC, BMJBASHH

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
SEP 14, 2021
Microbiology
Learn How Good Bugs Can Benefit Us at International Microorganism Day
SEP 14, 2021
Learn How Good Bugs Can Benefit Us at International Microorganism Day
Microorganisms live everywhere, and we've learned over the past year that they can affect everything.
OCT 10, 2021
Technology
Food and the Microbiome: Using Bioinformation Tools To Personalize Diet and Nutrition Plans
OCT 10, 2021
Food and the Microbiome: Using Bioinformation Tools To Personalize Diet and Nutrition Plans
According to a new study published in Nature Communications, researchers have developed a predictive bioinformatic syste ...
OCT 11, 2021
Genetics & Genomics
A Genetic Risk Factor is Shared by Alzheimer's and Severe COVID-19
OCT 11, 2021
A Genetic Risk Factor is Shared by Alzheimer's and Severe COVID-19
While amyloid plaques are a hallmark of Alzheimer's disease, the neurological disorder has also been linked to inflammat ...
NOV 14, 2021
Microbiology
Beneficial Bacteria May Help Fight Ear Infections Caused by Bacterial Pathogens
NOV 14, 2021
Beneficial Bacteria May Help Fight Ear Infections Caused by Bacterial Pathogens
Researchers have identified bacteria that have the potential to fight infections that affect the middle ear and can caus ...
NOV 30, 2021
Immunology
Sweet Escape: A Sugar Molecule Helps HIV Remain Incognito
NOV 30, 2021
Sweet Escape: A Sugar Molecule Helps HIV Remain Incognito
HIV is a master of disguise. Once the virus enters the body, it has a number of sophisticated mechanisms through which i ...
NOV 29, 2021
Microbiology
How the Hepatitis B Virus Promotes Liver Cancer Development
NOV 29, 2021
How the Hepatitis B Virus Promotes Liver Cancer Development
It's estimated that about 240 million people worldwide have an HBV infection. Hepatitis B infections are linked to t ...
Loading Comments...